e-Drug3D

368

DEFEROXAMINE


INN
DEFEROXAMINE

cas 70-51-9
CLASS

VARIOUS
IRON CHELATING AGENT
ANTIMALARIALS

ROUTE (list)

INJECTION

NATURAL MOLECULE (link)

ATC code

V03AC01

PK parameters

F 2 PERCENT
Tmax 0.5 HOUR
PPB 10 PERCENT
t1/2 6 HOUR

Solubility

FREELY SOLUBLE IN WATER


Target

TARGET XANTHINE DEHYDROGENASE/OXIDASE (PMID12169576)

DrugCentral

Unknown

Download SDF file N'-[5-(acetyl-hydroxyamino)pentyl]-N-[5-[[4-(5-aminopentyl-hydroxyamino)-4-oxobutanoyl]amino]pentyl]-N-hydroxybutanediamide

Formula:
C25H48N6O8

Calculated chemical properties:

MW 560.69
NB_atoms 39
XLogP 0.92
PSA 204.17
NB_HD 7
NB_HA 14
fsp3 0.80
Lipinski(0=no;1=yes) 0

FDA
NDA 016267 (pdf not found) INN (DEFEROXAMINE MESYLATE) DESFERAL (MITEM PHARMA) APPROVAL= AP YEAR= 1968
NDA 076019 (pdf not found) INN (DEFEROXAMINE MESYLATE) DEFEROXAMINE MESYLATE (HOSPIRA) APPROVAL= AP YEAR= 2004
NDA 076806 (pdf not found) INN (DEFEROXAMINE MESYLATE) DEFEROXAMINE MESYLATE (DR REDDYS) APPROVAL= AP YEAR= 2006 DISCONTINUED
NDA 078086 (pdf not found) INN (DEFEROXAMINE MESYLATE) DEFEROXAMINE MESYLATE (HIKMA) APPROVAL= AP YEAR= 2007
NDA 078718 (pdf not found) INN (DEFEROXAMINE MESYLATE) DEFEROXAMINE MESYLATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2009
NDA 207384 (pdf not found) INN (DEFEROXAMINE MESYLATE) DEFEROXAMINE MESYLATE (GLAND) APPROVAL= AP YEAR= 2017

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL